Literature DB >> 10586169

Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia.

M W Weber1, P Milligan, B Giadom, M A Pate, A Kwara, A D Sadiq, M Chanayireh, H Whittle, B M Greenwood, K Mulholland.   

Abstract

OBJECTIVE: To determine the frequency of later respiratory tract morbidity after respiratory syncytial virus (RSV) disease in infancy.
DESIGN: Cohort study with passive, clinic-based surveillance.
SETTING: Outpatient department in The Gambia.
SUBJECTS: One hundred five children admitted to the hospital with severe RSV disease (case cohort), 105 control children matched for age not admitted to the hospital during the previous RSV season (control cohort 1), and 102 control children born after the RSV season (control cohort 2). MAIN OUTCOME MEASURES: Frequencies of pneumonia, wheezing, and hospital admission with acute lower respiratory tract infection.
RESULTS: Pneumonia was more common in case children than in both control groups (adjusted incidence rate ratio [IRR, 95% CI]: 3.80 [2.73, 6. 10]), as was wheezing (IRR 7.33 [3.10,17.54]), pneumonia or wheezing (IRR 3.96 [2.60, 6.04]), and admission with pneumonia or wheezing (IRR 3.40 [1.87, 6.15]). The incidence rate per 100 child-years for pneumonia in the dry season for 12-month-old children was 27 for case patients, 8.1 for control cohort 1, and 6.51 for control cohort 2. By 3 years of age, the rates had fallen to low levels in all groups.
CONCLUSIONS: Pneumonia and wheezing are significantly more common in children after RSV-associated lower respiratory tract disease than in control subjects, but the incidence declines rapidly with increasing age.

Entities:  

Mesh:

Year:  1999        PMID: 10586169     DOI: 10.1016/s0022-3476(99)70085-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Genes associated with RSV lower respiratory tract infection and asthma: the application of genetic epidemiological methods to understand causality.

Authors:  Emma K Larkin; Tina V Hartert
Journal:  Future Virol       Date:  2015-07       Impact factor: 1.831

2.  Infant Respiratory Syncytial Virus Bronchiolitis and Subsequent Risk of Pneumonia, Otitis Media, and Antibiotic Utilization.

Authors:  Andrew Abreo; Pingsheng Wu; Brittney M Donovan; Tan Ding; Tebeb Gebretsadik; Xiang Huang; Cosby A Stone; Kedir N Turi; Tina V Hartert
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

3.  Pneumonia case-finding in the RESPIRE Guatemala indoor air pollution trial: standardizing methods for resource-poor settings.

Authors:  Nigel Bruce; Martin Weber; Byron Arana; Anaite Diaz; Alisa Jenny; Lisa Thompson; John McCracken; Mukesh Dherani; Damaris Juarez; Sergio Ordonez; Robert Klein; Kirk R Smith
Journal:  Bull World Health Organ       Date:  2007-07       Impact factor: 9.408

Review 4.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

5.  Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).

Authors:  Emma K Larkin; Tebeb Gebretsadik; Martin L Moore; Larry J Anderson; William D Dupont; James D Chappell; Patricia A Minton; R Stokes Peebles; Paul E Moore; Robert S Valet; Donald H Arnold; Christian Rosas-Salazar; Suman R Das; Fernando P Polack; Tina V Hartert
Journal:  BMC Pulm Med       Date:  2015-04-30       Impact factor: 3.317

6.  [Incidence of community-acquired infections of lower airways among infants].

Authors:  Ana Luisa Oenning Martins; Deisy da Silva Fernandes Nascimento; Ione Jayce Ceola Schneider; Fabiana Schuelter-Trevisol
Journal:  Rev Paul Pediatr       Date:  2016-03-02

Review 7.  Immunoprophylaxis of respiratory syncytial virus: global experience.

Authors:  Eric A F Simoes
Journal:  Respir Res       Date:  2002

Review 8.  Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease.

Authors:  Nele Sigurs
Journal:  Respir Res       Date:  2002-06-24

9.  A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial.

Authors:  Gabrielle B McCallum; Peter S Morris; Mark D Chatfield; Carolyn Maclennan; Andrew V White; Theo P Sloots; Ian M Mackay; Anne B Chang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

10.  Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya.

Authors:  Patrick Kiio Munywoki; Eric O Ohuma; Mwanajuma Ngama; Evasius Bauni; J Anthony G Scott; D James Nokes
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.